MedTrace Logo

Efficacy and Safety of Injection With VINCI Plus Hyaluronic Acid Filler

NCT01918839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-12-05

No results posted yet for this study

Summary

This clinical trial is intended to evaluate the efficacy and safety of injection with VINCI Plus as compared to Restylane-L® in correction of nasolabial fold.

Conditions

  • Nasolabial Fold Improvement

Interventions

DEVICE

VINCI Plus

VINCI Plus 1ml injected into wrinkle treatment area

DEVICE

Restylane-L

Restylane-L injected into wrinkle treatment area

Sponsors & Collaborators

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    collaborator OTHER

  • Seoul National University Hospital

    collaborator OTHER

  • D.med

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01918839 on ClinicalTrials.gov